This contract expires in 18 days (Jun 30, 2026).

Browse related active opportunities

COST PLUS FIXED FEE

LEIDOS BIOMEDICAL RESEARCH INC - DEVELOP A NONCOMPETITIVE MONOCLONAL ANTI-CD25

PIID: 75N91020F00034
Signed Date: Dec 11, 2025Effective Date: Sep 25, 2020End Date: Closes in 18 days
Award $
$1.3M
Vendor
LEIDOS BIOMEDICAL RESEARCH INC
NAICS
541715
Signed Date
Dec 11, 2025

Key Details

Dollars Obligated
$1.3M
Base & All Options
Awarding Sub-Agency
National Institutes of Health
Product Service Code
AN12 - HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH
Extent Competed
FULL AND OPEN COMPETITION
Place of Performance
FREDERICK, MD, 217029242, CD-MD-06

Description

DEVELOP A NONCOMPETITIVE MONOCLONAL ANTI-CD25

Context & Analysis

On Dec 11, 2025, Department of Health and Human Services obligated $1,275,555 to LEIDOS BIOMEDICAL RESEARCH INC for develop a noncompetitive monoclonal anti-cd25. The award is classified under NAICS 541715 — RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) and issued as a cost plus fixed fee contract. Competition extent: full and open competition. Performance is located in FREDERICK, MD. The contract is scheduled through Jun 30, 2026 — approximately 1 month remaining. This award is one of several similar procurements from Department of Health and Human Services under NAICS 541715 — related awards are listed below.

Contractor Information

UEI: HV8BH9BPG8Y9
CAGE Code: 3LYK6
Location: FREDERICK, MD
View Full Record on USASpending.gov

Stay Updated

Get notified about new opportunities matching your interests.

Related